Butyrate ameliorates maternal high-fat-diet-induced placental inflammation and offspring metabolic dysfunction via modulating gut microbiota in mice
European Journal of Nutrition · 2026-08 · 65 (5)
DOI: 10.1007/s00394-026-04018-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nutrition, online erschienen am 30.06.2026. Verfasst von Yidan Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Pediatric Research, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Diet, High-Fat, Gastrointestinal Microbiome, Butyrates, Placenta. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, Key Technologies Research and Development Program.
Abstract (Originalsprache)
BACKGROUND: Maternal high-fat diet (HFD) increases the risk of metabolic disorders in offspring. Placental inflammation acts as a critical mediator with poorly addressed etiology. Recently HFD-induced gut dysbiosis is demonstrated to be a key driver of systemic inflammation. Whether inflammatory signals triggered by HFD-induced gut dysbiosis are transmitted to the placenta via the maternal-fetal axis warrant further investigation. This study aims to elucidate the mechanistic connection between maternal gut dysbiosis and placental inflammation, thereby offering insights into microbiota-mediated developmental origins of metabolic diseases in offspring. METHODS: Female C57BL/6 mice were exposed to high fat diet (HFD) for 5 weeks prior to mating with male mice. Gut microbiota was profiled by using 16 S rRNA sequencing and fecal short-chain fatty acids (SCFAs) were quantified by GC-MS from HFD pregnant mice at gestational day 18.5 (G18.5). Mice were sacrificed at G18.5, and placenta histopathological analysis as well as inflammatory markers and lipopolysaccharide (LPS) level were analyzed. Anti-inflammatory effects of butyrate were evaluated in vitro by using HTR-8/Svneo cells and in vivo through gestational supplementation (0.3 mg/g body weight) in HFD-fed dams. RESULTS: Maternal HFD exposure induced significant placental inflammation as well as hepatic steatosis in the offspring. HFD-fed dams exhibited distinct gut dysbiosis with reduced fecal and serum SCFAs, which was accompanied by elevated placental LPS levels and exacerbated inflammatory responses. Butyrate treatment suppressed the expression of inflammatory cytokines in vitro through down-regulating the phosphorylation of NF-κB, ERK1/2 signaling pathways via G-protein-coupled receptor 41 (GPR41). Furthermore, gestational butyrate intervention effectively alleviated placental inflammation and mitigated fetal hepatic lipid deposition in HFD-exposed offspring. CONCLUSION: Placental inflammation caused by maternal HFD is closely associated with gut microbiota dysbiosis. Butyrate supplementation during gestation reduces placental inflammation and ameliorated offspring hepatic steatosis, highlighting the therapeutic potential of butyrate for mitigating the adverse metabolic programming effects upon maternal HFD exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Institute of Pediatric Research, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- School of Basic Medical Sciences, Shanghai Jiao Tong University, Shanghai, China.
- Department of Endocrinology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Gastroenterology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Immunology and Microbiology, Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Neonatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Förderung
- Natural Science Foundation of Shanghai Municipality
- Key Technologies Research and Development Program
Zitieren
APA
Xu, Y., Zhang, Q., Lu, X., Ji, P., He, Z., Wang, Y., & Dong, Y. (2026). Butyrate ameliorates maternal high-fat-diet-induced placental inflammation and offspring metabolic dysfunction via modulating gut microbiota in mice. European Journal of Nutrition, 65(5). https://doi.org/10.1007/s00394-026-04018-3
Vancouver
Xu Y, Zhang Q, Lu X, Ji P, He Z, Wang Y, et al. Butyrate ameliorates maternal high-fat-diet-induced placental inflammation and offspring metabolic dysfunction via modulating gut microbiota in mice. European Journal of Nutrition. 2026;65(5). doi:10.1007/s00394-026-04018-3
BibTeX
@article{Xu2026,
author = {Xu, Yidan and Zhang, Qianren and Lu, Xingyu and Ji, Ping and He, Zhenjuan and Wang, Ying and Dong, Yan},
title = {Butyrate ameliorates maternal high-fat-diet-induced placental inflammation and offspring metabolic dysfunction via modulating gut microbiota in mice},
journal = {European Journal of Nutrition},
year = {2026},
volume = {65},
number = {5},
doi = {10.1007/s00394-026-04018-3}
}
EUVIMED